If you need more lookups,
subscriptions start at $34 USD/month.
James Bolling Location
Chapel Hill, NC, US
James Bolling Work
2024 -now Vice President, Process Development and CMC Strategy @
2022 -2024 Senior Director, CMC Strategy @
2022 -2022 Associate Director, Cell Therapy Process Development @
2017 -2022 Team Lead, Cell Therapy Process Development @
2017 -2017 Associate Scientist II @
2015 -2017 Associate Scientist I @
2013 -2015 Research and Development Associate II @
2011 -2013 Graduate Researcher @
2012 -2012 Cell Culture Development Intern (Global Biologics Development) @
2009 -2011 Undergraduate Researcher @
2010 -2010 Research Assistant @
James Bolling Education
Northwestern University
M.S (Biotechnology (McCormick School of Engineering))
University of Virginia
BS; BA (Biology; Economics)
James Bolling Skills
Mammalian Tissue Culture
Bioreactor
Bioreactor Operation
Western Blotting
GMP
Agilent Hplc Systems
Media Development
Cell Signaling
Fluorescence Confocal Microscopy
Mac OS X
Sirna Gene Knockdown
Biotechnology
PCR
Cell And Molecular Biology
Life Sciences
Page And Agarose Gel Electrophoresis
Cell Culture
Reporter Gene Cellular Assays
JMP
Ambr15 And Ambr250 Automated Bioreactor Systems
FileMaker
Clonogenic Assays
Research And Development R&D
Microsoft Office
Windows 7
Molecular Cloning
Bioprocess Engineering
Flow Cytometry
Cellular Uptake And Cytotoxicity Assays
Research and Development
James Bolling Summary
James Bolling, based in Chapel Hill, NC, US, is currently a Vice President, Process Development and CMC Strategy at Precision BioSciences, Inc.. James Bolling brings experience from previous roles at Precision BioSciences, Inc. and MedImmune. James Bolling holds a M.S in Biotechnology (McCormick School of Engineering) @ Northwestern University. With a robust skill set that includes Mammalian Tissue Culture, Bioreactor, Bioreactor Operation, Western Blotting, GMP and more. James Bolling has 5 emails and 9 mobile phone numbers on RocketReach.
Looking for a different James Bolling?
Find contact details for 700 million professionals.